Phase III evaluation of once-daily, oral therapy with ICL670 (Exjade (R)) versus deferoxamine in patients with beta-thalassemia and transfusional hemosiderosis

Cappellini M., Bejaoui M., Perrotta S., Agaoglu L., Kattamis A., Giardina P., ...More

46th Annual Meeting of the American-Society-of-Hematology, California, United States Of America, 4 - 07 December 2004, vol.104, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 104
  • Doi Number: 10.1182/blood.v104.11.3619.3619
  • City: California
  • Country: United States Of America
  • Istanbul University Affiliated: No